Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer

Lignende værker

• Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
  af: Ioannis Alagkiozidis, et al.
  Udgivet: (2015-04-01)
• Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis
  af: Lili Huang, et al.
  Udgivet: (2022-08-01)
• Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
  af: Diane Pannier, et al.
  Udgivet: (2018-07-01)
• Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
  af: Rose Isono-Nakata, et al.
  Udgivet: (2018-05-01)
• Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
  af: Kiran Kumar, et al.
  Udgivet: (2020-01-01)